A non-invasive method of drug delivery, intranasal atomization, has shown positive results in human medicine and in some animal species. The objective of this study was to evaluate the effects of ...
SARASOTA, Fla., June 27, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today ...
Wednesday, Oragenics Inc. (NYSE:OGEN) announced the completion of its spray-dried formulation and filling in the nasal device for its lead candidate, ONP-002, for concussion. Oragenics is a ...
A nationwide recall has been issued for the MAD300 nasal atomizer, the device used to administer the heroin overdose drug naxalone. The recall does not impact the medication, according to a release ...
SARASOTA, Fla., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN) (“the Company”), a company focused on developing unique, intranasal pharmaceuticals for the treatment of ...
Administering medications through the nose as an alternative to injections or IVs is becoming increasingly popular in emergency departments and ambulances, according to a paper by Loyola Medicine ...
Full study evaluating two formulations of opioid reversal drug naloxone were published in Pain and Therapy PHILADELPHIA, April 1, 2019 /PRNewswire/ -- Design Science Consulting, Inc., today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results